Aptose Biosciences, Inc.
(Toronto Stock Exchange : APTO)

( )
APTO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.36%196.721.3%$541.68m
GILDGilead Sciences, Inc.
0.44%66.170.9%$360.03m
ALXNAlexion Pharmaceuticals, Inc.
-0.65%107.832.0%$325.54m
ILMNIllumina, Inc.
-0.87%298.273.5%$303.23m
BIIBBiogen Inc.
1.09%238.701.3%$299.70m
CELGCelgene Corporation
0.22%98.601.3%$288.37m
SRPTSarepta Therapeutics, Inc.
-2.46%84.8814.6%$178.86m
VRTXVertex Pharmaceuticals Incorporated
-0.87%176.001.9%$174.54m
AAgilent Technologies, Inc.
-0.97%76.401.6%$173.35m
REGNRegeneron Pharmaceuticals, Inc.
0.78%288.122.6%$172.60m
EXASExact Sciences Corporation
2.36%106.8724.1%$135.19m
ACADACADIA Pharmaceuticals Inc.
-3.20%42.6013.9%$114.97m
INCYIncyte Corporation
0.97%79.102.5%$85.71m
BMRNBioMarin Pharmaceutical Inc.
1.07%75.004.3%$71.23m
ALDRAlder Biopharmaceuticals, Inc.
1.08%18.7010.2%$63.94m

Company Profile

Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.